BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10989625)

  • 1. [Cervical cancer screening in the Bas-Rhin. Evaluation of four and a half years of the EVE campaign].
    Fender M; Schaffer P; Dellenbach P
    Sante Publique; 2000 May; 12 Spec No():11-20. PubMed ID: 10989625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Can we and must we organize cervical cancer screening in France? Results of the pilot project "EVE" in the department of Bas-Rhin].
    Fender M; Schaffer P; Dellenbach P
    J Gynecol Obstet Biol Reprod (Paris); 1998 Nov; 27(7):683-91. PubMed ID: 9921438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The "Action Woman Health" program in three Lyons suburbs].
    Mignotte H; Le Goaziou MF; Nachury LP; Pérol D; Fontaniere B; Fouillat V; Lasset C
    Sante Publique; 2000 May; 12 Spec No():45-58. PubMed ID: 10989628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cervical cancer screening campaign in Doubs: evaluation of the first three years of the pilot program].
    Gautier CP; Monnet E; Meslans Y
    Sante Publique; 2000 May; 12 Spec No():37-43. PubMed ID: 10989627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Recommendations from the experimental sites for implementing organized cervical cancer screening in France].
    Baudier F; Schapman S; Giordanella JP
    Sante Publique; 2000 May; 12 Spec No():71-88. PubMed ID: 10989630
    [No Abstract]   [Full Text] [Related]  

  • 6. [EVE, a regional campaign for the screening of cervical cancer. Organization, 7-years results and perspectives].
    Fender M; Schott J; Baldauf JJ; Muller J; Schlund E; Dellenbach P;
    Presse Med; 2003 Oct; 32(33):1545-51. PubMed ID: 14576592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Guidelines for the evaluation of internal quality control of smears for screening of uterine cancer in France in the structures of Pathologic Anatomy and Cytology. French Association for Quality Assurance in Pathologic Anatomy and Cytology (AFAQAP)--Commission for cervical smears].
    Albuisson F; Anger E; Baron V; Cartier I; Dorne H; Dubois-Gordeff A; Hassoun J; Jouannelle A; Labbé S; Locquet D; Marsan C; Martin E; Michiels-Marzias D; Molinié V; Mottot C; Mueller B; Vacher-Lavenu MC; Vincent S; Vuong PN
    Ann Pathol; 1998 Jul; 18(3):221-6. PubMed ID: 9750045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of a cervical cancer screening campaign: reflections on the experience in Martinique].
    Briollais L; Feyler A; Ossondo M; Dorival MJ; Le Mab G; Escarmant P; Azaloux H
    Sante Publique; 2000 May; 12 Spec No():21-35. PubMed ID: 10989626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cervical cancer screening for high risk women: is it possible? Results of a cervical cancer screening program in three suburban districts of Lyon].
    Mignotte H; Perol D; Fontanière B; Nachury LP; Blanc-Jouvand A; Fouillat V; Chauvin F; Lasset C
    Bull Cancer; 1999 Jun; 86(6):573-9. PubMed ID: 10417430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of the follow-up of women aged 50-74 years after cervical cytological Ascus abnormalities in cancer screening: adherence to clinical practice guidelines in Isere, France; 1991-2000].
    Billette-de-Villemeur A; Poncet F; Garnier A; Marron J; Le Marc'hadour F; Morens A; Rouault-Plantaz V; Ney M; Exbrayat C
    Gynecol Obstet Fertil; 2009 Oct; 37(10):787-95. PubMed ID: 19782628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Breast, cervical and colo-rectal simultaneous mass screening program for women 50 to 69 years old in Isere].
    Garnier A; Exbrayat C; Marron J; Seigneurin D; Winckel P; Bolla M
    Sante Publique; 2000 May; 12 Spec No():59-69. PubMed ID: 10989629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of screening for uterine cervix cancer: from theory to practice (author's transl)].
    Riotton G
    Bull Cancer; 1979; 66(4):404-6. PubMed ID: 526628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality control in cytopathology applied to screening for cervical carcinoma.
    Marsan C
    Pol J Pathol; 1995; 46(4):245-8. PubMed ID: 8713292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of cervical cancer screening program at a rural community of South Africa.
    Hoque M; Hoque E; Kader SB
    East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary care practice and facility quality orientation: influence on breast and cervical cancer screening rates.
    Goldzweig CL; Parkerton PH; Washington DL; Lanto AB; Yano EM
    Am J Manag Care; 2004 Apr; 10(4):265-72. PubMed ID: 15124503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cervical cancer screening programs: technical cooperation in the Caribbean.
    Barnett DB
    Bull Pan Am Health Organ; 1996 Dec; 30(4):409-12. PubMed ID: 9041754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Participation in highly subsidized cervical cancer screening by women in Enugu, South-east Nigeria.
    Obi SN; Ozumba BC; Nwokocha AR; Waboso PA
    J Obstet Gynaecol; 2007 Apr; 27(3):305-7. PubMed ID: 17464818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. European Guidelines for Quality Assurance in Cervical Cancer Screening. Europe against cancer programme.
    Coleman D; Day N; Douglas G; Farmery E; Lynge E; Philip J; Segnan N
    Eur J Cancer; 1993; 29A Suppl 4():S1-38. PubMed ID: 8274301
    [No Abstract]   [Full Text] [Related]  

  • 19. [The role of cancer registries in the evaluation of breast cancer screening].
    Schaffer P; Renaud R; Gairard B; Guldenfels C
    Rev Epidemiol Sante Publique; 1996; 44 Suppl 1():S15-21. PubMed ID: 8935860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cervical cancer screening: A Slovenian experience.
    Primic-Zakelj M; Repse-Fokter A
    Coll Antropol; 2007 Apr; 31 Suppl 2():23-6. PubMed ID: 17600934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.